Clinical Trials Directory

Trials / Unknown

UnknownNCT03262207

Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours

Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours: Potential Risks and Consequences for the Conceptus

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

Recent data suggest that sperm cells carry an epigenetic message during spermatogenesis and that this message is crucial for the future development of the embryo. This epigenetic signature is notably represented by methylation of genes subjected to imprinting (GSI) and the methylation of transposable elements (TE). Data on the maintenance of the imprint and of the control of TE accompanying human gametogenesis in a context of adult germinal testicular cancers, seminomas, are extremely fragmentary for tumour tissues and inexistent for gametes. The aim of this study is to determine whether patients with seminomas in comparison with fertile men carry a higher risk of presenting epigenetic alterations affecting their gametes. This study is based on the use of an existing collection of biological samples. 90 samples will be selected and split into 3 groups: * Group 1: 30 sperm samples from patients with seminomatous testicular tumours * Group 2: 30 sperm samples from fertile patients * Group 3: 30 sperm samples from infertile patients After treatment of the samples (thawing, cell sorting and removal of cryoprotectants), they will be analysed.

Conditions

Interventions

TypeNameDescription
OTHERExtraction genomic DNA
OTHERAnalysis of methylation profiles of numerous GSI and TE
OTHERAnalysis of methylation for the whole genome (sub-population of 15 samples from group 1)
OTHERMethod of protein detection by immunostaining and flow cytometry

Timeline

Start date
2016-09-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2017-08-25
Last updated
2017-08-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03262207. Inclusion in this directory is not an endorsement.